Background In recent years, the incidence of P neumocystis jirovecii pneumonia (PJP) has
increased in immunocompromised patients without human immunodeficiency virus (HIV) …

The rates of Pneumocystis pneumonia (PcP) are increasing in the HIV-negative susceptible
population. Guidance for the prophylaxis and treatment of PcP in HIV, haematology, and …

Purpose The purpose of our study was to determine the relative frequencies of causes of
widespread ground-glass opacity (GGO) in an unselected, consecutive patient population …

The aim of the study was to explore the frequency and dynamics of acquisition and
colonization of Pneumocystis jirovecii among neonates, as well as the epidemiological and …

Purposes Data on PCP in patients with glomerular disease are rare. The aim of this study
was to assess the predictors of PCP development, the risk factors for mortality and the …

Background Interstitial lung disease (ILD) is a new risk category for pneumocystis
pneumonia (PCP) with a high mortality rate. The definite diagnostic criteria of PCP in ILD …

目的探讨耶氏肺孢子菌的形态学特征, 有利于检验人员从形态学角度早发现,
早诊断该罕见病原体. 分析不同的病原体检测方法在耶氏肺孢子菌肺炎诊断中的实验室特点和 …

Multiple opportunistic coinfections during corticosteroid therapy for the nephrotic syndrome
are uncommon. Infection-associated hemophagocytic lymphohistiocytosis (HLH) is a rare …

Objectives Pneumocystis jirovecii pneumonia (PCP) can differ in HIV and non HIV
population due to degree of immunity. This study was undertaken with an aim to highlight …

ABSTRACT AIM: Pneumocystis pneumonia (PCP) has a high mortality rate in HIV-negative
immunocompromised patients, but is preventable with antimicrobial prophylaxis. We aimed …